Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intention to treat analysis is related to methodological quality.

Literature DB >> 10753165

Intention to treat analysis is related to methodological quality.

M Ruiz-Canela, M A Martínez-González, J de Irala-Estévez.

Abstract

Mesh：

Year: 2000 PMID： 10753165 PMCID： PMC1117880

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

3 in total

Review 1. What is meant by intention to treat analysis? Survey of published randomised controlled trials.

Authors: S Hollis; F Campbell
Journal: BMJ Date: 1999-09-11

2. Informed consent and approval by institutional review boards in published reports on clinical trials.

Authors: M Ruiz-Canela; M A Martínez-González; E Gómez-Gracia; J Fernández-Crehuet
Journal: N Engl J Med Date: 1999-04-08 Impact factor: 91.245

3. Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors: C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal: JAMA Date: 1996-08-28 Impact factor: 56.272

3 in total

14 in total

Review 1. Intention-to-treat principle.

Authors: V M Montori; G H Guyatt
Journal: CMAJ Date: 2001-11-13 Impact factor: 8.262

2. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors: David Moher; Kenneth F Schulz; Douglas G Altman
Journal: Clin Oral Investig Date: 2003-01-31 Impact factor: 3.573

3. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors: David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal: BMJ Date: 2010-03-23

Review 4. [CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design].

Authors: D Moher; K F Schulz; D G Altman
Journal: Schmerz Date: 2005-04 Impact factor: 1.107

10. Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin.

Authors: S Swaroop Vedula; Tianjing Li; Kay Dickersin
Journal: PLoS Med Date: 2013-01-29 Impact factor: 11.069

Intention to treat analysis is related to methodological quality.

Review 1. What is meant by intention to treat analysis? Survey of published randomised controlled trials.

2. Informed consent and approval by institutional review boards in published reports on clinical trials.

3. Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Review 1. Intention-to-treat principle.

2. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

3. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Review 4. [CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design].

Review 5. Pragmatic randomised controlled trials in parenting research: the issue of intention to treat.

6. Standards of reporting of randomized controlled trials in general surgery: can we do better?

Review 7. Methodological quality and reporting of ethical requirements in clinical trials.

8. Modified intention to treat reporting in randomised controlled trials: systematic review.

9. Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data.

10. Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin.